Abstract
A primary rat hepatocyte culture system has been developed for the study of peroxisome proliferation. Maximal induction of peroxisomal activity requires supplementation of the culture medium with hydrocortisone. The addition of clofibric acid (0.01–1 mM), mono-(2-ethylhexyl)phthalate (0.01–0.5 mM) and trichloroacetic acid (0.1–5 mM) to cultured rat hepatocytes resulted in a time- and dose-related increase in CN- insensitive palmitoyl CoA oxidation (maximal increases: 27-, 15.5-, and 5-fold respectively) and mitochondrial α-glycerophosphate dehydrogenase activity (maximal increases: 7.3-, 5.8-, and 1.6-fold respectively). Electron microscopic examination revealed smooth endoplasmic reticulum proliferation and morphometric analysis indicated an increase in fractional peroxisomal volume of X 8 and X 4 for clofibric acid (1 mM) and trichloroacetic acid (2.5 mM), respectively. SDS-PAGE of cell homogenates revealed an intensified protein band of mol. wt. 76–78,000. The induction of peroxisomal β-oxidation by clofibric acid was elevated from 9- to 12-fold by supplementation of the medium with l-carnitine (2mM).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bock P, Kramar R, Pavelka M (1980) Peroxisomes and related particles in animal tissues. Cell Biology Monographs, vol 7. Springer, Berlin Heidelberg New York
Bronfman M, Inestrosa NC, Leighton F (1979) Fatty acid oxidation by human liver peroxisomes. Biochem Biophys Res Comm 88: 1030–1036
Christansen RZ, Bremer J (1976) Active transport of γ-butyrobetaine and carnitine into isolated liver cells. Biochim Biophys Acta 448: 562–577
De Duve C, Badhuin P (1966) Peroxisomes (microbodies and related particles). Physiol Rev 46: 323–357
Elcombe CR, Pratt IS, Green T (1982) The rate of trichloroacetic acid formation determines the species difference in hepatic peroxisome proliferation due to trichloroethylene (TRI). Pharmacologist 24: 173
Fringes B, Reith A (1982) Time course of peroxisome biogenesis during adaptation to mild hyperthyroidism in rat liver. A morphometric/sterologic study by electron microscopy. Lab Invest 47: 19–26
Fritz IB, Kaplan E, Yue KTN (1962) Specificity of carnitine action on fatty acid oxidation by heart muscle. Am J Physiol 202: 117–121
Gray TJB, Beamand JA, Lake BG, Foster JR, Gangolli SD (1982) Peroxisome proliferation in cultured rat hepatocytes produced by clofibrate and phthalate ester metabolites. Toxicol Lett 10: 273–279
Gray TJB, Lake BG, Beamand JA, Foster JR, Gangolli SD (1983) Peroxisome proliferation in primary cultures of rat hepatocytes. Toxicol Appl Pharmacol 67: 15–25
Hess R, Staubli W, Riess W (1965) Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature 208: 856–858
Holloway BR, Orton TC (1979) The effect of hypolipidaemic agents on hepatic peroxisomal and microsomal drug metabolising enzymes in relation to thyroxine modulation. Proc BPS, 17–19 December 1979, 318 P
Holloway BR, Bentley M, Thorp JM (1982) Species differences in the effects of ICI 55,897 on plasma lipids and hepatic peroxisomes. Ann NY Acad Sci 386: 439–442
Horie S, Ishii H, Suga T (1981) Changes in peroxisomal fatty acid oxidation in the diabetic rat liver. J Biochem. 90: 1691–1696
Ishii H, Suga T (1979) Clofibrate-like effects of acetylsalicylic acid on peroxisomes and on hepatic and serum triglyceride levels. Biochem Pharmacol 28: 2829–2833
Laemmli UK, Favre M (1973) Maturation of the head of bacteriophage T4.1 DNA packaging event. J Mol Biol 80: 575
Lake BG, Grasso P, Lloyd AG (1975) Studies on the hepatic effects of orally administered di(2-ethylhexyl)phthalate in the rat. Toxicol Appl Pharmacol 32: 355–367
Lazarow PB (1981) Assay of peroxisomal β-oxidation of fatty acids. In: Lowenstein JM (ed) Methods in enzymology, vol 72: Lipids, part D. Academic Press, pp 315–317
Lee YP, Lardy HA (1965) Influence of thyroid hormones on L-α-glycerophosphate dehydrogenase and other dehydrogenases in various organs of the rat. J Biol Chem 240: 1427–1436
Lee YP, Takemori AE, Lardy H (1959) Enhanced oxidation of α-glycerophosphate by mitochondria of thyroid-fed rats. J Biol Chem 234: 3051–3054
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275
Markwell AK, Bieber LL, Tolbert NE (1977) Differential increase of hepatic peroxisomal, mitochondria, and microsomal carnitine acyl transferases in clofibrate-fed rats. Biochem Pharmacol 26: 1697–1703
Markwell MAK, McGroarty EJ, Bieber LL, Tolbert NE (1973) The subcellular distribution of carnitine acyl transferases in mammalian liver and kidney. J Biol Chem 248: 3426–3432
Masters C, Holmes R (1977) Peroxisomes: New aspects of cell physiology and biochemistry. Physiol Rev 57: 816–882
McGarry JD, Robles-Valdes C, Foster DW (1975) Role of carnitine in hepatic ketogenesis. Proc Natl Acad Sci USA 72: 4385–4388
Pande SV, Parvin R (1980) Clofibrate enhancement of mitochondrial transport system of rat liver and augmentation of liver carnitine and γ-butyrobetaine hydroxylase activity by thyroxine. Biochim Biophys Acta 617: 363–370
Rao ML, Rao GS, Holler M, Breuer H, Schattenberg PJ, Stein WD (1976) Uptake of cortisol by isolated rat liver cells. A phenomenon indicative of carrier-mediation and simple diffusion. Hoppe Seylers Z Physiol Chem 357: 573–584
Reddy JK, Azarnoff DL, Hignite CE (1980) Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 283: 397–398
Reddy JK, Krishnakantha TP (1975) Hepatic peroxisome proliferation: Induction by two novel compounds structurally unrelated to clofibrate. Science 190: 787–789
Reddy JK, Kumar NS (1977) The peroxisome proliferation-associated polypeptide in rat liver. Biochem Biophys Res Commun 77: 824–829
Reddy JK, Qureshi SA (1979) Tumorigenicity of the hypolipidaemic peroxisome proliferator ethyl-α-p-chlorophenoxy isobutyrate (clofibrate) in rats. Br J Cancer 40: 476
Reddy JK, Rao MS (1977) Malignant tumours in rats fed nafenopin, a hepatic peroxisome proliferator. J Natl Cancer Inst 59: 1645–1651
Reddy JK, Svoboda DJ, Azarnoff DL (1973) Microbody proliferation in liver induced by nafenopin, a new hypolipidaemic drug: Comparison with CPIB. Biochem Biophys Res Commun 52: 537–543
Reddy JK, Warren JR, Reddy MK, Lalwani ND (1982) Hepatic and renal effects of peroxisome proliferators: Biological implications. Ann NY Acad Sci 386: 81–110
Svoboda DJ, Azarnoff DL (1979) Tumours in male rats fed ethylchlorophenoxyisobutyrate, a hypolipidaemic drug. Cancer Res 39: 3419–3428
Tolbert NE, Essner E (1981) Microbodies: Peroxisomes and glyoxysomes. J Cell Biol 91: 271s-283s
Warren JR, Simmon VF, Reddy JK (1980) Properties of hypolipidaemic peroxisome proliferators in the lymphocyte: [3H]-thymidine and salmonella mutagenesis assays. Cancer Res 40: 36–41
Weibel ER, Staubli W, Guagi HR, Hess FA (1969) Correlated morphometric and biochemical studies on the liver cell. I. Morphometric model, stereolytic methods and normal morphometric data for rat liver. J Cell Biol 42: 68–91
Wicks WD (1974) MTP International Review of Science. In: Rickenberg (ed) Biochemistry series one, vol 8. Butterworths University Park Press p 216
Wilson EJ, McMurray WC (1980) Insulin and cortisol increase the response of rat hepatocytes in primary culture to 3,3′,5-triiodothyronine. Biochem Biophys Res Commun 93: 179–185
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mitchell, A.M., Bridges, J.W. & Elcombe, C.R. Factors influencing peroxisome proliferation in cultured rat hepatocytes. Arch Toxicol 55, 239–246 (1984). https://doi.org/10.1007/BF00341018
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00341018